China Pharma Holdings (CPHI) Gross Profit Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 7.62% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.71% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 12.55% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 76.85% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.80% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.95% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -35.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 37.26% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 44.16% |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | 17.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.07% |
| Dec 31, 2025 | 52.30% |
| Sep 30, 2025 | 24.34% |
| Jun 30, 2025 | 27.61% |
| Mar 31, 2025 | 7.06% |
| Dec 31, 2024 | -36.30% |
| Sep 30, 2024 | -20.58% |
| Jun 30, 2024 | -153.56% |
| Mar 31, 2024 | -45.23% |
| Dec 31, 2023 | -28.89% |
| Sep 30, 2023 | -90.75% |
| Jun 30, 2023 | -28.62% |
| Mar 31, 2023 | -2.92% |
| Dec 31, 2022 | -47.16% |
| Sep 30, 2022 | -33.32% |
| Jun 30, 2022 | -50.41% |
| Mar 31, 2022 | -31.19% |
| Dec 31, 2021 | 55.60% |
| Sep 30, 2021 | -37.12% |
| Jun 30, 2021 | -50.33% |